According to SurgePays's latest financial reports the company has $14.62 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $14.62 M | 107.83% |
2022-12-31 | $7.03 M | 11.97% |
2021-12-31 | $6.28 M | 832.28% |
2020-12-31 | $0.67 M | 94.77% |
2019-12-31 | $0.34 M | -22.17% |
2018-12-31 | $0.44 M | -65.11% |
2017-12-31 | $1.27 M | 1899.97% |
2016-12-31 | $0.06 M | -8.32% |
2015-12-31 | $0.06 M | 137.08% |
2014-12-31 | $0.02 M | |
2014-04-30 | $0 M | -33.2% |
2013-04-30 | $0 M | 52.53% |
2012-04-30 | $0 M | -55.87% |
2011-04-30 | $0 M | -76.34% |
2010-04-30 | $0 M | -89.18% |
2009-04-30 | $0.02 M | |
2007-11-30 | $0 M | -98.08% |
2006-11-30 | $0.07 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $26.21 B | 179,203.93% | ๐บ๐ธ USA |
Novartis NVS | $9.69 B | 66,196.91% | ๐จ๐ญ Switzerland |
Stryker Corporation SYK | $2.40 B | 16,361.38% | ๐บ๐ธ USA |
Cooper Companies COO | $0.13 B | 824.63% | ๐บ๐ธ USA |
STAAR Surgical STAA | $0.22 B | 1,409.54% | ๐บ๐ธ USA |
CONMED CNMD | $33.85 M | 131.53% | ๐บ๐ธ USA |
Integra LifeSciences IART | $0.30 B | 2,013.90% | ๐บ๐ธ USA |